Cite

HARVARD Citation

    Bodei, L. et al. (2020). Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy. Lancet oncology. 21 (9), pp. e431-e443. [Online]. 
  
Back to record